AMWL AMERICAN WELL CORP

Amwell® Announces Results for Fourth Quarter and Full Year 2024

Amwell® Announces Results for Fourth Quarter and Full Year 2024

BOSTON, Feb. 12, 2025 (GLOBE NEWSWIRE) -- ® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based technology-enabled healthcare platform, today announced financial results for the fourth quarter and full year ended Dec. 31, 2024. Visit Amwell’s investor relations website at to view the fourth quarter and full year 2024 earnings report.

The company will host a conference call to discuss its financial results today at 5 p.m. ET, Feb. 12. The call can be accessed via a live audio webcast at . A replay of the call will be available via webcast shortly after the completion of the call, at .

About Amwell

Amwell is a leading hybrid care, delivery enablement platform in the United States and globally, connecting and enabling providers, payers, patients, and innovators to deliver greater access to more affordable, higher quality care. Amwell believes that hybrid care delivery will transform healthcare. We offer a single, comprehensive platform to support all digital health needs from urgent to acute and post-acute care, as well as chronic care management and healthy living. With nearly two decades of experience, Amwell powers the digital care of 50 health plans, which collectively represent more than 80 million covered lives, and many of the nation’s largest health systems. For more information, please visit . For more information, please visit .

©2025 American Well Corporation. All rights reserved. Amwell®, SilverCloud®, Amwell Converge™, Carepoint™ and the Amwell Logo are registered trademarks or trademarks of American Well Corporation.



Contacts

Media:
Angela Vogen
 

Investors:
Sue Dooley
 
EN
12/02/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on AMERICAN WELL CORP

 PRESS RELEASE

Amwell® makes grants to new employees under inducement plan

Amwell® makes grants to new employees under inducement plan BOSTON, Feb. 21, 2025 (GLOBE NEWSWIRE) --  (NYSE: AMWL), a leading technology-enabled care platform provider, announced that on Feb. 18, Amwell made grants of RSUs covering an aggregate of 16,737 shares of its Class A common stock to four new employees. The grants were offered as material inducement to the employees’ employment with Amwell. The RSUs will vest as follows, subject to the applicable employee’s continued employment through the applicable vesting date: 25% of the RSUs will vest upon the first anniversary of the grant ...

 PRESS RELEASE

Amwell® to participate in upcoming investor conference

Amwell® to participate in upcoming investor conference BOSTON, Feb. 19, 2025 (GLOBE NEWSWIRE) -- ® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based technology-enabled healthcare platform, will participate in an upcoming investor conference. Ido Schoenberg, M.D., Amwell chairman and chief executive officer, will participate in a fireside chat and one-on-one meetings at the TD Cowen 24th Annual Health Care conference in Boston on March 4. The fireside chat will be at 9:10 a.m. ET and an audio webcast of the fireside chat will be available at . About Amwell  Amwell offers paye...

 PRESS RELEASE

Amwell® Announces Results for Fourth Quarter and Full Year 2024

Amwell® Announces Results for Fourth Quarter and Full Year 2024 BOSTON, Feb. 12, 2025 (GLOBE NEWSWIRE) -- ® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based technology-enabled healthcare platform, today announced financial results for the fourth quarter and full year ended Dec. 31, 2024. Visit Amwell’s investor relations website at to view the fourth quarter and full year 2024 earnings report. The company will host a conference call to discuss its financial results today at 5 p.m. ET, Feb. 12. The call can be accessed via a live audio webcast at . A replay of the call will...

 PRESS RELEASE

Amwell® to report fourth quarter and full year 2024 operating results

Amwell® to report fourth quarter and full year 2024 operating results BOSTON, Jan. 29, 2025 (GLOBE NEWSWIRE) -- ® (NYSE: AMWL), a leader in digital care, will report fourth quarter 2024 operating results after stock market trading hours on Wednesday, Feb. 12. Following the distribution of the earnings alert via wire services, the Amwell management team will host a live conference call and webcast at 5 p.m. ET to review the company's operating results and provide a general business update. The full earnings report and the live audio webcast can be accessed by visiting the...

 PRESS RELEASE

Amwell® adds Vida to its clinical programs portfolio expanding access ...

Amwell® adds Vida to its clinical programs portfolio expanding access to obesity and diabetes care Vida to offer cardiometabolic solutions including GLP-1s and other anti-obesity medications on the Amwell platform BOSTON and SAN FRANCISCO, Jan. 15, 2025 (GLOBE NEWSWIRE) -- ® (NYSE: AMWL), a leader in digital care, today announced that , a leader in virtual cardiometabolic care, is now part of the clinical programs portfolio on the Amwell platform. The program, Amwell Cardiometabolic Care Powered by Vida, will be available to Amwell’s expansive client footprint of health plans and emplo...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch